GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 166 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $233,000 | +1.7% | 9,763 | -37.8% | 0.00% | – |
| Q4 2020 | $229,000 | +172.6% | 15,691 | +165.9% | 0.00% | – |
| Q3 2020 | $84,000 | -75.6% | 5,901 | -74.7% | 0.00% | – |
| Q2 2020 | $344,000 | +421.2% | 23,363 | +44.9% | 0.00% | – |
| Q1 2020 | $66,000 | +3.1% | 16,127 | +21.2% | 0.00% | – |
| Q4 2019 | $64,000 | +45.5% | 13,308 | +84.5% | 0.00% | – |
| Q3 2019 | $44,000 | -55.6% | 7,214 | -52.5% | 0.00% | – |
| Q2 2019 | $99,000 | 0.0% | 15,203 | +8.6% | 0.00% | – |
| Q1 2019 | $99,000 | +47.8% | 13,995 | +1.4% | 0.00% | – |
| Q4 2018 | $67,000 | -36.2% | 13,796 | -3.5% | 0.00% | – |
| Q3 2018 | $105,000 | +118.8% | 14,298 | +92.0% | 0.00% | – |
| Q2 2018 | $48,000 | +4700.0% | 7,448 | +2742.7% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 262 | -39.6% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 434 | +173.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 159 | +43.2% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 111 | -4.3% | 0.00% | – |
| Q1 2017 | $1,000 | -99.8% | 116 | -99.7% | 0.00% | – |
| Q4 2016 | $452,000 | +976.2% | 36,926 | +936.7% | 0.00% | – |
| Q3 2016 | $42,000 | +223.1% | 3,562 | +140.2% | 0.00% | – |
| Q2 2016 | $13,000 | -92.9% | 1,483 | -95.7% | 0.00% | – |
| Q1 2016 | $184,000 | +1740.0% | 34,760 | +2615.6% | 0.00% | – |
| Q4 2015 | $10,000 | -33.3% | 1,280 | -31.4% | 0.00% | – |
| Q3 2015 | $15,000 | -40.0% | 1,866 | -32.8% | 0.00% | – |
| Q2 2015 | $25,000 | -43.2% | 2,778 | -19.1% | 0.00% | – |
| Q1 2015 | $44,000 | -58.5% | 3,432 | -56.2% | 0.00% | – |
| Q4 2014 | $106,000 | +231.2% | 7,834 | +120.9% | 0.00% | – |
| Q3 2014 | $32,000 | +14.3% | 3,546 | +71.1% | 0.00% | – |
| Q2 2014 | $28,000 | -65.4% | 2,073 | -74.7% | 0.00% | – |
| Q1 2014 | $81,000 | -77.6% | 8,188 | -69.9% | 0.00% | – |
| Q4 2013 | $362,000 | +36100.0% | 27,180 | +47584.2% | 0.00% | – |
| Q3 2013 | $1,000 | – | 57 | +62.9% | 0.00% | – |
| Q2 2013 | $0 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |